Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Vaccine Adjuvants Market Analysis & Forecast (2018-2023) - Expanding Government Recommendations for Immunizations Drives the Market -

Research and Markets
Posted on: 07 Dec 18

The "Vaccine Adjuvants Market - Segmented By Type, Mechanism of action (Active immunostimulants, Carriers, and Vehicle adjuvants), and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to's offering.

Expanding government recommendations for immunizations, increasing technological innovations, unmet vaccine market needs for certain diseases, and increasing use of recombinant subunit and synthetic vaccines are the major factors contributing to the growth of the global vaccine adjuvants market which is expected to reach USD 1,036.40 million in 2023.

Key Highlights

  • Expanding Government Recommendations for Immunizations Drives the Vaccine Adjuvants Market
  • Side Effects of Adjuvants is Restricting the Growth of the Vaccine Adjuvants Market
  • Mineral Salt Based Adjuvants has the Largest Market Share
  • Vehicle Adjuvants have Registered a High CAGR
  • North America is Anticipated to Dominate the Vaccine Adjuvants Market

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Vaccine Adjuvants Market Overview

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

6.1 Market Drivers

6.1.1 Expanding government recommendations for immunizations

6.1.2 Technological innovations

6.1.3 Unmet Vaccine market needs for certain diseases

6.1.4 Increasing use of recombinant subunit and synthetic vaccines

6.2 Market Restraints

6.2.1 Side effects of adjuvants

6.2.2 High toxicity adjuvants

6.2.3 High R&D developing a new adjuvant

7. Market Segmentation

7.1 By type

7.2 By Mechanism of action

7.3 By Geography

7.3.1 North America

7.3.2 Europe

7.3.3 AsiaPacific

7.3.4 Middle East & Africa

7.3.5 South America

8. Competitive Landscape

9. Company Profiles

9.1 Invivogen

9.2 Sigma Aldrich (Merck KGaA)

9.3 Seppic (Air Liquide Group)

9.4 Oz Biosciences

9.5 Novavax, Inc

9.6 Adjuvatis

9.7 Vaxliant

9.8 Adjuvance Technologies, Inc

10. Future of the Market

For more information about this report visit

View source version on

Business Wire

Last updated on: 07/12/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.